Original contributionPathologic patternsof Serratia marcescens pneumonia**
References (23)
- et al.
Hospital-acquired pneumonia
Med clin North Am
(1974) Serratia marcescens: historical perspective and clinical review
N Engl J Med
(1979)- et al.
Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak
Ann Intern Med
(1970) An outbreak of Serratia marcescens and its control
Arch Intern Med
(1969)- et al.
A hospital outbreak of Serratia marcescens associated with ultrasonic nebulizers
Ann Intern Med
(1968) - et al.
An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread
J Infect Dis
(1976) - et al.
Serratia marcescens: biochemical characterstics, antibiotic susceptibility patterns, and clinical significance
JAMA
(1970) - et al.
Serratia marcescens: a pathogen of increasing clinical importance
JAMA
(1970) - et al.
Characteristics of Serratia marcescens pneumonia
Arch Intern Med
(1973) - et al.
Serratia pneumonia
Radiology
(1980)
From supersition to science: the history of a bacterium
Trans NY Acad Sci
Cited by (15)
Cavitated pulmonary nodules in a female patient with breast cancer: Keep in mind Serratia marcescens’ infections
2021, Respiratory Medicine Case ReportsCitation Excerpt :In 9 patients, the pathogens caused haemorrhagic bronchopneumonia, with micro-abscesses and cavitated lesions; vessels larger than 75 μm were also observed, due to the presence of vasculitis. In the remaining patients – represented by a population of 7 neutropenic cases – more extensive and diffuse pneumonia was found, sometimes resembling a diffuse alveolar damage lung pattern, with intra-alveolar fibrinous exudates and haemorrhage [10]. In our clinical case, the radiological appearance was similar to the morphological condition of a Serratia infection in non-neutropenic patients: no signs of diffuse alveolar damage were observed on CT images.
Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance
2022, npj Biofilms and MicrobiomesThe pathology of legionellosis part I: Pulmonary pathology
2018, Legionellosis
- **
This paper was presented at the Seventieth Annual Meeting of the US-Canadian Division of the International Academy of Pathology, Chicago, Ill, March 1981.
- *
Research Fellow, Departments of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass.
- 1
Dr. Goldstein is supported in part by National Research Service Award 4-T32-HLO7066-05.
- †
Pathologist, Brigham and Women's Hospital, and Assistant Professor of Pathology, Harvard Medical School, Boston, Mass.
- ‡
Director, Division of Oncoradiology, Sidney Farber CancerInstitute, and Associate Professor of Radiology, Harvard Medical School, Boston, Mass.
- §
Director, Division of Thoracic Radiology, Brigham andWomen's Hospital, and Professor of Radiology, Harvard Medical School, Boston, Mass.